Aloe emodin inhibits the cytotoxic action of tumor necrosis factor

European Journal of Pharmacology

Volumn 568, Issue 1-3, 2007, Pages 248-259

  Harhaji, Ljubica ^a   Mijatovic, Sanja ^a   Maksimovic Ivanic, Danijela ^a   Popadic, Dusan ^b   Isakovic, Aleksandra ^b   Todorovic Markovic, Biljana ^c   Trajkovic, Vladimir ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Aloe emodin; Apoptosis; Autophagy; Cytotoxicity; Extracellular signal regulated kinase; Necrosis; Tumor necrosis factor

Indexed keywords

3 METHYLADENINE; ALOE EMODIN; ANTHRAQUINONE DERIVATIVE; BAFILOMYCIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR;

ACIDIFICATION; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL PROTECTION; CELL STRAIN L 929; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HERB; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; EMODIN; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTORS;

EID: 34250800832     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.029     Document Type: Article

References (70)

1. Acevedo-Duncan M., Russell C., Patel S., and Patel R. Aloe emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells. Int. Immunopharmacol. 4 (2004) 1775-1784
2. 2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int. 65 (2004) 1231-1239
3. Arosio B., Gagliano N., Fusaro L.M., Parmeggiani L., Tagliabue J., Galetti P., De Castri D., Moscheni C., and Annoni G. Aloe emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol. Toxicol. 87 (2000) 229-233
4. Bauvy C., Gane P., Arico S., Codogno P., and Ogier-Denis E. Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp. Cell Res. 268 (2001) 139-149
5. Beyaert R., and Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett. 340 (1994) 9-16
6. Blommaart E.F.C., Krause U., Schellens J.P.M., Vreeling-Sindelarova H., and Meijer A.J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243 (1997) 240-246
7. Brune B. Nitric oxide: NO apoptosis or turning it ON?. Cell Death Differ. 10 (2003) 864-869
8. Bulfone-Paus S., Bulanova E., Pohl T., Budagian V., Durkop H., Ruckert R., Kunzendorf U., Paus R., and Krause H. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain. FASEB J. 13 (1999) 1575-1585
9. Bursch W., Hochegger K., Torok L., Marian B., Ellinger A., and Hermann R.S. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 113 (2000) 1189-1198
10. Cha T.L., Qiu L., Chen C.T., Wen Y., and Hung M.C. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res. 65 (2005) 2287-2295
11. Chang N.S. Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-β1. Am. J. Physiol. 273 (1997) C1987-C1994
12. Chang L.C., Sheu H.M., Huang Y.S., Tsai T.R., and Kuo K.W. A novel function of emodin: enhancement of the nucleotide excision repair of UV- and cisplatin-induced DNA damage in human cells. Biochem. Pharmacol. 58 (1999) 49-57
13. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22 (1984) 27-55
14. Codogno P., and Meijer A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12 Suppl 2 (2005) 1509-1518
15. Denecker G., Vercammen D., Declercq W., and Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58 (2001) 356-370
16. Duvoix A., Delhalle S., Blasius R., Schnekenburger M., Morceau F., Fougere M., Henry E., Galteau M.M., Dicato M., and Diederich M. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor-κB inhibition. Biochem. Pharmacol. 68 (2004) 1101-1111
17. Fady C., Gardner A., Jacoby F., Briskin K., Tu Y., Schmid I., and Lichtenstein A. Atypical apoptotic cell death induced in L929 targets by exposure to tumor necrosis factor. J. Interferon Cytokine Res. 15 (1995) 71-80
18. Ghavami S., Hashemi M., Kadkhoda K., Alavian S.M., Bay G.H., and Los M. Apoptosis in liver diseases - detection and therapeutic applications. Med. Sci. Monit. 11 (2005) RA337-RA3345
19. Goossens V., De Vos K., Vercammen D., Steemans M., Vancompernolle K., Fiers W., Vandenabeele P., and Grooten J. Redox regulation of TNF signaling. Biofactors 10 (1999) 145-156
20. Hamaguchi E., Takamura T., Shimizu A., and Nagai Y. Tumor necrosis factor-α and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase-and nuclear factor-κB-dependent pathways in cultured human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 307 (2003) 987-994
21. Huang Q., Shen H.M., and Ong C.N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochem. Pharmacol. 68 (2004) 361-371
22. Huang Q., Shen H.M., and Ong C.N. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell. Mol. Life Sci. 62 (2005) 1167-1175
23. Huang Q., Shen H.M., Shui G., Wenk M.R., and Ong C.N. Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway. Cancer Res. 66 (2006) 5807-5815
24. Humphreys D.T., and Wilson M.R. Modes of L929 cell death induced by TNF-α and other cytotoxic agents. Cytokine 11 (1999) 773-782
25. Jia L., Dourmashkin R.R., Allen P.D., Gray A.B., Newland A.C., and Kelsey S.M. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br. J. Haematol. 98 (1997) 673-685
26. Kanzawa T., Kondo Y., Ito H., Kondo S., and Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63 (2003) 2103-2108
27. Kanzawa T., Germano I.M., Komata T., Ito H., Kondo Y., and Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11 (2004) 448-457
28. Kiffin R., Bandyopadhyay U., and Cuervo A.M. Oxidative stress and autophagy. Antioxid. Redox Signal. 8 (2006) 152-162
29. Kirstein M., Fiers W., and Baglioni C. Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis. J. Immunol. 137 (1986) 2277-2280
30. Kitagawa D., Tanemura S., Ohata S., Shimizu N., Seo J., Nishitai G., Watanabe T., Nakagawa K., Kishimoto H., Wada T., Tezuka T., Yamamoto T., Nishina H., and Katada T. Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J. Biol. Chem. 277 (2002) 366-371
31. Kovarikova M., Hofmanova J., Soucek K., and Kozubik A. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status. Differentiation 72 (2004) 23-31
32. Kuo Y.C., Tsai W.J., Meng H.C., Chen W.P., Yang L.Y., and Lin C.Y. Immune reponses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi. Life Sci. 68 (2001) 1271-1286
33. Kuo P.L., Lin T.C., and Lin C.C. The antiproliferative activity of aloe emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 71 (2002) 1879-1892
34. Lee H.Z., Hsu S.L., Liu M.C., and Wu C.H. Effects and mechanisms of aloe emodin on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol. 431 (2001) 287-295
35. Leist M., Gantner F., Bohlinger I., Germann P.G., Tiegs G., and Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153 (1994) 1778-1788
36. Lemasters J.J. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 276 (1999) G1-G6
37. Lin C.C., Chang C.H., Yang J.J., Namba T., and Hattori M. Hepatoprotective effects of emodin from Ventilago leiocarpa. J. Ethnopharmacol. 52 (1996) 107-111
38. Liu Y., Tergaonkar V., Krishna S., and Androphy E.J. Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor-α correlates with increased accumulation of reactive oxygen species. J. Biol. Chem. 274 (1999) 24819-24827
39. Los M., Mozoluk M., Ferrari D., Stepczynska A., Stroh C., Renz A., Herceg Z., Wang Z.Q., and Schulze-Osthoff K. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell 13 (2002) 978-988
40. Lucas R., Kresse M., Latta M., and Wendel A. Tumor necrosis factor: how to make a killer molecule tumor-specific?. Curr. Cancer Drug Targets. 5 (2005) 381-392
41. Luschen S., Scherer G., Ussat S., Ungefroren H., and Adam-Klages S. Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-κB, elicits caspase activity, and enhances cytotoxicity. Exp. Cell Res. 293 (2004) 196-206
42. Luster M.I., Simeonova P.P., Gallucci R.M., Bruccoleri A., Blazka M.E., Yucesoy B., and Matheson J.M. The role of tumor necrosis factor alpha in chemical-induced hepatotoxicity. Ann. N. Y. Acad. Sci. 919 (2000) 214-220
43. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Popadic D., Momcilovic M., Harhaji L., Miljkovic D., and Trajkovic V. Aloe emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism. Cell. Mol. Life Sci. 61 (2004) 1805-1815
44. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic D., Harhaji L., Vuckovic O., Stosic-Grujicic S., Mostarica Stojkovic M., and Trajkovic V. Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell. Mol. Life Sci. 62 (2005) 589-598
45. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic D., Kaludjerovic G.N., Sabo T.J., and Trajkovic V. Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin. Cell. Mol. Life Sci. 62 (2005) 1275-1282
46. Nakamoto T., Inagawa H., Takagi K., and Soma G. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors. Anticancer Res. 20 (2000) 4087-4096
47. Paglin S., Hollister T., Delohery T., Hackett N., McMahill M., Sphicas E., Domingo D., and Yahalom J. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61 (2001) 439-444
48. Pecere T., Gazzola M.V., Mucignat C., Parolin C., Vecchia F.D., Cavaggioni A., Basso G., Diaspro A., Salvato B., Carli M., and Palu G. Aloe emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 60 (2000) 2800-2804
49. Pecere T., Sarinella F., Salata C., Gatto B., Bet A., Dalla Vecchia F., Diaspro A., Carli M., Palumbo M., and Palu G. Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe emodin. Int. J. Cancer 106 (2003) 836-847
50. Piret J.P., Arnould T., Fuks B., Chatelain P., Remacle J., and Michiels C. Caspase activation precedes PTP opening in TNF-α-induced apoptosis in L929 cells. Mitochondrion 3 (2004) 261-278
51. Shepard H.M., and Lewis G.D. Resistance of tumor cells to tumor necrosis factor. J. Clin. Immunol. 8 (1988) 333-341
52. Spriggs D.R., Sherman M.L., Michie H., Arthur K.A., Imamura K., Wilmore D., Frei III E., and Kufe D.W. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J. Natl. Cancer Inst. 80 (1988) 1039-1044
53. Strelow A., Bernardo K., Adam-Klages S., Linke T., Sandhoff K., Kronke M., and Adam D. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192 (2000) 601-612
54. Su Y.T., Chang H.L., Shyue S.K., and Hsu S.L. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 70 (2005) 229-241
55. Trent J.C., McConkey D.J., Loughlin S.M., Harbison M.T., Fernandez A., and Ananthaswamy H.N. Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J. 15 (1996) 4497-4505
56. Vandenabeele P., Declerq W., Beyaert R., and Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5 (1995) 392-399
57. Vassalli P. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10 (1992) 411-452
58. Vath P., Wamer W.G., and Falvey D.E. Photochemistry and phototoxicity of aloe emodin. Photochem. Photobiol. 75 (2002) 346-352
59. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., and Vandenabeele P. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188 (1998) 919-930
60. Vrablic A.S., Albright C.D., Craciunescu C.N., Salganik R.I., and Zeisel S.H. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. FASEB J. 15 (2001) 1739-1744
61. Wamer W.G., Vath P., and Falvey D.E. In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Radic. Biol. Med. 34 (2003) 233-242
62. Wang X., Li N., Liu B., Sun H., Chen T., Li H., Qiu J., Zhang L., Wan T., and Cao X. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor-α-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization. J. Biol. Chem. 279 (2004) 45855-45864
63. Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., and Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23 (1998) 33-42
64. Yeh F.T., Wu C.H., and Lee H.Z. Signalling pathway for aloe emodin-induced apoptosis in human H460 lung nonsmall carcinoma cell. Int. J. Cancer 106 (2003) 26-33
65. Yi J., Yang J., He R., Gao F., Sang H., Tang X., and Ye R.D. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res. 64 (2004) 108-116
66. Yim T.K., Wu W.K., Mak D.H., and Ko K.M. Myocardial protective effect of an anthraquinone-containing extract of Polygonum multiflorum ex vivo. Planta Med. 64 (1998) 607-611
67. Zhang L., and Hung M.C. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 12 (1996) 571-576
68. Zhang L., Chang C.J., Bacus S.S., and Hung M.C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res. 55 (1995) 3890-3896
69. Zhang L., Lau Y.K., Xia W., Hortobagyi G.N., and Hung M.C. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin. Cancer Res. 5 (1999) 343-353
70. Zhang X.P., Li Z.F., Liu X.G., Wu Y.T., Wang J.X., Wang K.M., and Zhou Y.F. Effects of emodin and baicalein on rats with severe acute pancreatitis. World J. Gastroenterol. 11 (2002) 2095-2100